DK1562976T3 - Syntese af estetrol via estron-afledte steroider - Google Patents

Syntese af estetrol via estron-afledte steroider

Info

Publication number
DK1562976T3
DK1562976T3 DK03772962T DK03772962T DK1562976T3 DK 1562976 T3 DK1562976 T3 DK 1562976T3 DK 03772962 T DK03772962 T DK 03772962T DK 03772962 T DK03772962 T DK 03772962T DK 1562976 T3 DK1562976 T3 DK 1562976T3
Authority
DK
Denmark
Prior art keywords
estetrol
estrone
synthesis
derived steroids
group
Prior art date
Application number
DK03772962T
Other languages
English (en)
Inventor
Mark Theodoor Verhaar
Thomas Koch
Erwin Gerardus Jacobus Warmerdam
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of DK1562976T3 publication Critical patent/DK1562976T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
DK03772962T 2002-11-08 2003-11-07 Syntese af estetrol via estron-afledte steroider DK1562976T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079676 2002-11-08
PCT/NL2003/000782 WO2004041839A2 (en) 2002-11-08 2003-11-07 Synthesis of estetrol via estrone derived steroids

Publications (1)

Publication Number Publication Date
DK1562976T3 true DK1562976T3 (da) 2010-08-16

Family

ID=32309415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03772962T DK1562976T3 (da) 2002-11-08 2003-11-07 Syntese af estetrol via estron-afledte steroider

Country Status (13)

Country Link
US (3) US20060211669A1 (da)
EP (1) EP1562976B1 (da)
CN (1) CN100343269C (da)
AT (1) ATE469165T1 (da)
AU (1) AU2003279624A1 (da)
CA (1) CA2505190C (da)
CY (1) CY1110237T1 (da)
DE (1) DE60332754D1 (da)
DK (1) DK1562976T3 (da)
ES (1) ES2346053T3 (da)
PT (1) PT1562976E (da)
SI (1) SI1562976T1 (da)
WO (1) WO2004041839A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG195118A1 (en) * 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
RS55231B1 (sr) 2011-10-07 2017-02-28 Estetra Sprl Postupak proizvodnje estetrola
WO2013034780A2 (en) 2012-12-20 2013-03-14 Crystal Pharma, S.A.U. Process for the preparation of estetrol and related compounds
EP3046928B1 (en) 2013-09-18 2017-02-08 Crystal Pharma, S.A.U. Process for the preparation of estetrol
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
PL3661520T3 (pl) * 2017-08-01 2022-03-28 Fund Sa Terapia adiuwantowa do stosowania w leczeniu raka prostaty
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
HU231240B1 (hu) * 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
IT201900017414A1 (it) 2019-09-27 2021-03-27 Ind Chimica Srl Processo per la preparazione di (15α,16α,17β)-estra-1,3,5(10)-triene-3,15,16,17-tetrolo (Estetrolo) ed intermedi di detto processo
GB2603868B (en) * 2019-09-27 2023-10-11 Ind Chimica Srl Process for preparing (15ALPHA,16ALPHA,17BETA)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-tetrol monohydrate (estetrol monohydrate) and intermediates of said process
IT201900021879A1 (it) 2019-11-22 2021-05-22 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROLO (ESTETROLO) ED INTERMEDI DI DETTO PROCESSO
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
IT202100019631A1 (it) 2021-07-23 2023-01-23 Newchem S P A Metodo per produrre estetrolo e i suoi intermedi
WO2023021026A1 (en) 2021-08-17 2023-02-23 Aspen Oss B.V. A synthetic pathway to estra-1,3,5(10)-triene-3,15a,16a,17b-tetrol
DE112021008305T5 (de) 2021-10-01 2024-07-25 Industriale Chimica S.R.L. VERFAHREN ZUR HERSTELLUNG VON (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) UND ESTETROL-MONOHYDRAT
WO2023209017A1 (en) 2022-04-26 2023-11-02 Mithra R&D Sa Process for the production of estetrol intermediates
AU2023428138A1 (en) 2023-02-02 2025-09-04 Industriale Chimica S.R.L. PROCESS FOR PREPARING (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) MONOHYDRATE
CN117088928B (zh) * 2023-08-16 2025-09-09 湖北共同甾体药物研究院有限公司 用于制备高纯度雌四醇的工艺
CN121605114A (zh) 2023-08-30 2026-03-03 埃斯特拉私人有限责任公司 雌四醇中间体的制造方法
HUP2400151A1 (hu) 2024-02-28 2025-09-28 Richter Gedeon Nyrt Ösztetrol-monohidrát kristályosítási eljárás

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138588A (en) * 1962-08-24 1964-06-23 American Home Prod 17-ketals of estrone and derivatives thereof
US3177206A (en) * 1963-03-07 1965-04-06 American Home Prod Selective bromination of a-ring aromatic 17-ketalized steroids
US3433785A (en) * 1966-07-11 1969-03-18 Sterling Drug Inc 15,16-disubstituted aromatic steroids,intermediates and processes
US3673180A (en) * 1970-06-18 1972-06-27 Merck & Co Inc 19-nor-6,6-ethylene-20-spiroxenes
DD144266A1 (de) * 1979-06-13 1980-10-08 Helmut Kasch Verfahren zur herstellung von delta hoch 15-17-ketosteroiden der oestran-und androstanreihe
US4739078A (en) * 1984-02-17 1988-04-19 The Upjohn Company Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
US5340586A (en) * 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
PT1390040E (pt) 2001-05-18 2007-04-30 Pantarhei Bioscience Bv Composição farmacêutica para ser utilizado na terapia hormonal de substituição.
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
EP1390042B1 (en) 2001-05-23 2007-11-28 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
ES2337129T3 (es) 2001-05-23 2010-04-21 Pantarhei Bioscience B.V. Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
WO2003018026A1 (en) 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
US8026228B2 (en) 2001-11-15 2011-09-27 Pantarhei Bioscience B.V. Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
EP1910528A2 (de) 2005-07-25 2008-04-16 Technische Universität Dresden Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
GB0621926D0 (en) 2006-11-03 2006-12-13 Medlock Medical Ltd Multi directional stretch tubular bandages
EP2077272A1 (en) 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
EP2077273B1 (en) 2007-12-31 2011-09-14 Animal Technology Institute Taiwan Methods for separating casein from soluble proteins in a composition

Also Published As

Publication number Publication date
US20150105362A1 (en) 2015-04-16
AU2003279624A1 (en) 2004-06-07
EP1562976B1 (en) 2010-05-26
ES2346053T3 (es) 2010-10-08
DE60332754D1 (de) 2010-07-08
CA2505190C (en) 2012-07-10
WO2004041839A2 (en) 2004-05-21
ATE469165T1 (de) 2010-06-15
CY1110237T1 (el) 2015-01-14
WO2004041839A3 (en) 2004-07-01
SI1562976T1 (sl) 2010-08-31
WO2004041839A8 (en) 2005-07-21
CN1735627A (zh) 2006-02-15
US20180265540A1 (en) 2018-09-20
EP1562976A2 (en) 2005-08-17
US20060211669A1 (en) 2006-09-21
PT1562976E (pt) 2010-08-12
CA2505190A1 (en) 2004-05-21
US10000524B2 (en) 2018-06-19
CN100343269C (zh) 2007-10-17

Similar Documents

Publication Publication Date Title
DK1562976T3 (da) Syntese af estetrol via estron-afledte steroider
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
DK1838677T3 (da) Krystallinske former af (R)-8-chlor-1.methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
ATE452882T1 (de) Herstellung von quetiapin
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
PL373774A1 (pl) Sposób wytwarzania izobutenu z technicznego eterumetylo-tert-butylowego
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE425121T1 (de) Verfahren zur umwandlung von polysulfanen
NO20071634L (no) Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner
DK1325022T3 (da) Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
IS6876A (is) Aðferð til að framleiða mesýlöt af píperasín afleiðum
IS7834A (is) Aðferð til nýmyndunar á bensímídasólefnasambandi
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60225595D1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
AR027327A1 (es) Procedimiento para la separacion einzimatica de racematos de derivados de aminometil-aril-ciclohezanol
BR0214445B1 (pt) processos para a produção de compostos.
DK1343808T3 (da) Fremgangsmåde til syntese af et LHRA-peptid
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.
IT1319682B1 (it) Procedimento di sintesi del paclitaxel.
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
MY143831A (en) Insecticidal incense composition, and emulsion and process for producing the same
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей